Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Efficacy of Positron Emission Tomography in Diagnosing Pulmonary Tumor and Staging of Lung Cancer : Comparing to Computed Tomography

폐종양과 폐암의 병기결정에 대한 양전자단층촬영(PET)의 유용성 -전산화단층촬영 (CT)과의 비교-

  • 김오곤 (서울대학교병원 흉부외과, 서울대학교 의과대학 흉부외과학 교실) ;
  • 조중행 (서울대학교병원 흉부외과, 서울대학교 의과대학 흉부외과학 교실) ;
  • 성숙환 (서울대학교병원 흉부외과, 서울대학교 의과대학 흉부외과학 교실)
  • Published : 2003.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Diagnosing and determining the stage of lung cancer by means of positron emission tomography (PET) ha.. been proven valuable because of the limitations of diagnosis by computed tomography (CT). We compared the efficacy of PET with that of CT in diagnosing pulmonary tumor and staging of lung cancer Material and Method: We performed F-18 FDG PET to determine the malignancy and the staging on patients who have been suspicious or were diagnosed as lung cancer by chest X-ray and CT. The findings of PET and of CT of 41 patients (male, 29: female, 12: mean age, 59) were compared with pathologic findings obtained from a mediastinoscopy and thoracotomy. Result: Out of 41 patients, 35 patients had malignant lesions (squamous cell carcinonla 19 cases, adenocarcinoma 14 cases, adenosquamous cell carcinoma 2 cases) and 6 patients had benign lesions. Diagnosing of lung cancer, the sensitivity, specificity and accuracy of CT and PET were the same for two method and the numbers were 100%, 50%, and 92.7% respectively. Eighteen LN groups out of 108 mediastinal LN groups who recieved histologic examination proved to be malignant. Pathologic lymph node (LN) stage was N0-Nl 31 cases, N2 8 cases, N3 2 cases. The correct identification of the nodal staging with CT, PET scans were 31 cases (75.6%), 28 cases (68.3%) respectively. The LN group was underestimated in each 6 cases of CT and PET. In 4 cases of CT and 7 cases of PET, they were overestimated in compare to histologic diagnosis. In the detection of mediastinal LN groups invasion, the sensitivity, specificity and accuracy of CT were 39.8 %, 93.3 %, and 84.3 % respectively. For PET, they were 61.1 %, 90.0 %, and 85.2 %. When two methods considered together (CT+PET), they were increased to 77.8 %, 93.3 %, and 90.7 % respectively. Conclusion: PET appears to be similar to CT in the diagnosis and the nodal taging of pulmonary tumor. Two tests may stage patients with lung cancer more accurately than CT alone.

배경: 흉부 전산화 단층촬영(CT)의 폐암 진단율의 한계로 인하여 최근 폐암에 대한 진단과 병기결정에 양전자단층촬영(PET)이 유정한 것으로 알려져 있다. 이에 우리나라 폐암 환자에서 진단 및 병기 결정에 전산화 단층촬영과 양전자단층촬영의 진단율의 차이점과 유용성을 비교하고자 하였다. 대상 및 방법: 1998년 6월부터 1999년 12월까지 흥부 X-선 촬영과 CT에서 폐암이 의심퇴거나 진단된 55명에서, 차 장기에서 폐로 전이된 9명과 폐암수술후 재발된 5명을 제외한 41명을 대상으로 수술전 CT와 PET 소견과 종격동경이나 개흉술로 확진된 조직병리 소견을 비교하였다. 결과: 41명 대상환자 중 폐종양의 조직학적 진단은 악성병변이 35례 (편평세포암 19례, 선암 14례, 선편평세포암 2례)있고, 양성병변은 6례였다. 폐종양의 악성여부에 대한 CT와 PET 두가지 검사의 민감도, 특이도, 정확도는 같았으며 각각 100%, 50%, 92.7%였다. 최종적인 병리적 림프 절군 병기는 N0-Nl 31례, N2 8례, N3 2례 였다. 림프절군 병기가 일치하는 경우는 CT가 31례, PET가 28례였고, CT와 PET의 각간 6례에서 병리학적 림프절 병기보나 낮게 평가되었고, CT의 4례, PET의 7례에서 병기보다 높게 평가되었다. 조직검사가 가능했던 108개비 종격동 림프절군 중 18개 림프절군에서 악성으고 나왔고, 종격동 림프절군 침범여부에 대한 CT와 PET의 민감도, 특이도, 정확도는 각각 39.8%, 93.3%. 84.3%와 61.1%, 90.0%, 85.2% 였다. 종격동 림프절군 대한 CT와 PET 검사를 종합하여 같이 분석하였을 때 민감도 77.8%, 특이도 93.3%, 정확도 90.7%이었다. 결론: 폐종양과 림프절군의 병기 설정에 있어 PET검사는 CT와 비교하여 비슷한 유용성이 있는 건사로 사료되며, CT와 PET두 검사를 같이 시행하여 검토할 때 정착도를 높일 수 있다고 여겨진다.

Keywords

References

  1. 대흉외지 v.31 비소세포 폐암의 임파절 병기판정에 대한 흉부 전산화 단층 촬영의 효용성 연구 성숙환;김영태;김두상;김주현;임정기
  2. 대한방사선의학회지 v.32 no.4 비소세포성 폐암의 병기 판정에 있어서 CT와 MRI의 정확도 평가 최영희;임정기;송군식(외 8인)
  3. Radiology v.186 TI lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT Jean,M.S.;John,R.M.;Roberta,R.M.(et al.)
  4. 대한핵의학회지 v.31 no.1 CT상 악성여부가 불명확한 단일 폐결절에서의 양전자 방출단층촬영술의 유용성 윤석부;김병태;최준영(외 7인)
  5. 대한핵의학회지 v.31 no.3 수술 후 암 재발 판정에 있어서 전신 F-18 FDG-PET의 유용성 강원준;소영;정재민(외 9인)
  6. 대한핵의학회지 v.31 no.3 PET의 임상이용 고창순
  7. Radiology v.191 Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images Wahl,R.L.;Quint,L.E.;Greenough,R.L.;Meyer,C.R.;White,R.I.;Orringer,M.B. https://doi.org/10.1148/radiology.191.2.8153308
  8. Radiology v.202 Non-small cell lung cancer: nodal staging with FDG PET ersus CT with correlative lymph node mapping and sampling Steinert,H.C.;Hauser,M.;Allemann,F.(et al.) https://doi.org/10.1148/radiology.202.2.9015071
  9. Thorax v.52 Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography(PET) Guhlmann,A.;Storck,M.;Kotzerke,J.;Moog,F.;Sunder-Plassmann L.;Reske,S.N. https://doi.org/10.1136/thx.52.5.438
  10. J Clin Oncol v.16 Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients Vansteenkiste,J.F.;Stroobants,S.G.;De Leyn PR(et al.)
  11. J Thorac Cardiovasc Surg v.110 Detection of primary and recurrent lung cancer by mead of F-18 fluorodeoxyglucose positron emission tomography(FGD PET) Duhaylongsod,F.G.;Lowe,V.J.;Pata,E.F.(et al.) https://doi.org/10.1016/S0022-5223(05)80018-2
  12. Eur J Cardiothorac Surg v.12 no.1 Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography Hagberg,R.C.;Segall,G.M.;Stark,P.;Burrdon,T.A.;Pompili,M.F. https://doi.org/10.1016/S1010-7940(97)00159-0
  13. Ann Thorac Surg v.66 no.3 Detection of exrathoracic metastases by posiron emission tomography in lung cancer Weder,W.;Schmid,R.A.;Bruchhaus,H.;Hillinger,S.;von Schulthess,G.K.;Steinert,H.C. https://doi.org/10.1016/S0003-4975(98)00675-4
  14. Ann Surg v.229 no.2 Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer Gupta,N.C.;Graeber,G.M.;Rogers,T.S.2nd;Bishop,H.A. https://doi.org/10.1097/00000658-199902000-00018
  15. J Thorac Cardiovasc Surg v.117 Positron emission-tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease Graeber,G.M.;Gupta,N.C.;Murray,G.F. https://doi.org/10.1016/S0022-5223(99)70292-8
  16. Ann Thorac Surg v.73 An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Akhurst,T.;Downey,R.J.;Cinsberg,M.S.(et al.) https://doi.org/10.1016/S0003-4975(01)03257-X
  17. Br J Surg v.85 no.11 Controlled prospective study of positron emission tomography using the glucose analogue[18f] fluorodeoxyglucose in the evaluation of pulmonary nodules Prauer,H.W.;Weber,W.A.;Romer,W.;Treumann,T.;Ziegler,S.I.;Schwaiger,M. https://doi.org/10.1046/j.1365-2168.1998.00915.x
  18. J Nucl Med v.31 Differential diagnosis of lung tumor with PET: a prospective study Kubota,K.;Matsuzawa,T.;Fujiwara,T.(et al.)
  19. Mayo Clin Proc v.65 An integrated approach to evaluation of the solitary pulmonary nodule Swensen,S.J.;Jett,J.R.;Payne,W.S.;Viggiano,R.W.;Pairolero,P.C.;Trastec,V.F. https://doi.org/10.1016/S0025-6196(12)65012-5
  20. J Clin Oncol v.16 Analytical decision model for the cost effective management of solitary pulmonary nodules Gambhir,S.S.;Shephered,J.E.;Shah,B.D.(et al.) https://doi.org/10.1200/JCO.1998.16.6.2113
  21. Ann Surg v.66 no.6 Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis Scott,W.J.;Shepherd,J.;Gambhir,S.S. https://doi.org/10.1016/S0003-4975(98)01055-8
  22. Kaku Igaku v.34 no.5 Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan Kubota,K.;Yamada,S.;Fukuda,H.(et al.)
  23. Ann Thorac Surg v.67 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Saunders,C.A.B.;Dussek,J.E.;O'Doherty,M.J.(et al.) https://doi.org/10.1016/S0003-4975(98)01257-0